SCOPUS 정보 검색 플랫폼

Schizophrenia Research

Volumn 56, Issue 1-2, 2002, Pages 19-23

D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia

(5) Evins, A Eden a Amico, Ed a Posever, Thomas A b Toker, Rob b Goff, Donald C a

a Freedom Trail Clinic (United States)

b TUFTS UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

D Cycloserine; Glutamate; Glycine; Negative symptoms; NMDA; Schizophrenia

Indexed keywords

CYCLOSERINE; NEUROLEPTIC AGENT; PLACEBO; RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MALE; NEGATIVE SYNDROME; PRIORITY JOURNAL; RATING SCALE;

ADULT; ANTIPSYCHOTIC AGENTS; CYCLOSERINE; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0036641749 PISSN: 09209964 EISSN: None Source Type: Journal
DOI: 10.1016/S0920-9964(01)00220-1 Document Type: Article

Times cited : (120)

References (21)

1
- 0028785179
- New insights into the biology of schizophrenia through the mechanism of action of clozapine
- (1995) Neuropsychopharmacology , vol.13 , pp. 177-213
- Brunello, N.¹ Masotto, C.² Steardo, L.³ Markstein, R.⁴ Racagni, G.⁵

2
- 0028174008
- D-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia
- (1994) J. Neural. Transm. Gen. Sect. , vol.95 , pp. 105-111
- Cascella, N.G.¹ Macciardi, F.² Cavallini, C.³ Smeraldi, E.⁴

3
- 0029030343
- Antipsychotic agents antagonize non-competitive NMDA antagonist-induced behaviors
- (1995) Psychopharmacology , vol.120 , pp. 67-74
- Corbett, R.¹ Camacho, R.² Woods, A.T.³ Kerman, L.L.⁴ Fishkin, R.J.⁵ Brooks, K.⁶ Dunn, R.W.⁷

4
- 0030044715
- The glutamatergic dysfunction hypothesis for schizophrenia
- (1996) Harvard Rev. Psychiatry , vol.3 , pp. 241-253
- Coyle, J.T.¹

5
- 0025949567
- Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo
- (1991) Neuropharmacology , vol.30 , pp. 1167-1171
- Emmett, M.¹ Mick, S.² Cler, J.³

6
- 0030665569
- Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics
- (1997) J. Neural. Transm. , vol.104 , pp. 761-766
- Evins, A.E.¹ Amico, E.T.² Shih, V.³ Goff, D.C.⁴

7
- 0034058017
- A placebo controlled trial of glycine added to clozapine in schizophrenia
- (2000) Am. J. Psychiatry , vol.157 , pp. 826-828
- Evins, A.¹ Fitzgerald, S.² Wine, L.³ Rosselli, R.⁴ Goff, D.⁵

8
- 0029116094
- Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia
- (1995) Am. J. Psychiatry , vol.152 , pp. 1213-1215
- Goff, D.C.¹ Tsai, G.² Manoach, D.S.³ Coyle, J.T.⁴

9
- 0029853426
- D-Cycloserine added to clozapine for patients with schizophrenia
- (1996) Am. J. Psychiatry , vol.153 , pp. 1628-1630
- Goff, D.C.¹ Tsai, G.² Manoach, D.S.³ Flood, J.⁴ Darby, D.G.⁵ Coyle, J.T.⁶

10
- 0033557737
- A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia
- (1999) Biol. Psychiatry , vol.45 , pp. 512-514
- Goff, D.C.¹ Henderson, D.C.² Evins, A.E.³ Amico, E.⁴

11
- 0032902238
- A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia
- (1999) Arch. Gen. Psychiatry , vol.56 , pp. 21-27
- Goff, D.C.¹ Tsai, G.² Levitt, J.³ Amico, E.⁴ Manoach, D.⁵ Schoenfeld, D.A.⁶ Hayden, D.L.⁷ McCarley, R.⁸ Coyle, J.T.⁹

12
- 0032925438
- Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia
- (1999) Arch. Gen. Psychiatry , vol.56 , pp. 29-36
- Heresco-Levy, U.¹ Javitt, D.C.² Ermilov, M.³ Mordel, C.⁴ Silipo, G.⁵ Lichtenstein, M.⁶

13
- 0028015607
- Amelioration of negative symptoms in schizophrenia by glycine
- (1994) Am. J. Psychiatry , vol.151 , pp. 1234-1236
- Javitt, D.C.¹ Zylberman, I.² Zukin, S.R.³ Heresco-Levy, U.⁴ Lindenmayer, J.P.⁵

14
- 0024351536
- The schedule for the deficit syndrome: An instrument for research in schizophrenia
- (1989) Psychiatry Res. , vol.30 , pp. 119-123
- Kirkpatrick, B.¹ Buchanan, R.² McKenney, P.³

15
- 0023754192
- Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes
- (1988) Science , vol.241 , pp. 835-837
- Kleckner, N.W.¹ Dingledine, R.²

16
- 0028870612
- Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors
- (1995) Eur. J. Pharmacol. , vol.280 , pp. R9-R11
- Maurel-Remy, S.¹ Bervoets, K.² Millan, M.J.³

17
- 0028850552
- Glutamate receptor dysfunction and schizophrenia
- (1995) Arch. Gen. Psychiatry , vol.52 , pp. 998-1007
- Olney, J.W.¹ Farber, N.B.²

18
- 0032955821
- Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia
- (1999) Am. J. Psychiatry , vol.156 , pp. 145-147
- Potkin, S.G.¹ Jin, Y.² Bunney, B.G.³ Costa, J.⁴ Gulasekaram, B.⁵

19
- 0032403626
- D-Serine added to antipsychotics for the treatment of schizophrenia
- (1998) Biol. Psychiatry , vol.44 , pp. 1081-1089
- Tsai, G.¹ Yang, P.² Chung, L.C.³ Lange, N.⁴ Coyle, J.T.⁵

20
- 0032700978
- D-Serine added to clozapine for the treatment of schizophrenia
- (1999) Am. J. Psychiatry , vol.156 , pp. 1822-1825
- Tsai, G.E.¹ Yang, P.² Chung, L.C.³ Tsai, I.C.⁴ Tsai, C.W.⁵ Coyle, J.T.⁶

21
- 0025141342
- D-Cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes
- (1990) Brain Res. , vol.510 , pp. 158-160
- Watson, G.B.¹ Bolanowski, M.A.² Baganoff, M.P.³ Deppeler, C.L.⁴ Lanthorn, T.H.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.